Pharmicell Co.,Ltd. CEO Kim Hyun Soo group keeps 11.72% stake, extends share-backed loan
PAI summary · Not investment advice
Kim Hyun Soo and related parties kept their 11.72% stake in Pharmicell Co.,Ltd. and extended a share-backed loan covering 399,003 shares, due 2027.01.04.
Total under contracts
399,003 shares
Total 0.66%
Key facts
- Stake
- 11.72%Previous 11.72% · 0%p
- Reporting holder
- Kim Hyun Soo and 8 related parties
- Previous stake
- 11.72%
- Purpose of holding
- To influence management
- Relationship with issuer
- Largest shareholder
- Report type
- Amendment
- Reason for report
- Extension of a share pledge agreement
- Previous shares held
- 7,033,144 shares
- Shares held
- 7,033,144 shares
- Reason for amendment
- Extension of a share pledge agreement
- Previous shares under major contracts
- 399,003 shares
- Shares under major contracts
- 399,003 shares
- Reporting obligation date
- Oct 6, 2026
Commentary
AI commentary · Not investment advice
What happened
Kim Hyun Soo, CEO and largest shareholder of Pharmicell, extended a loan backed by his shares (a share pledge agreement). The pledge covers 399,003 shares with Woori Investment Securities. The loan is KRW 2.4 billion at 5.5% interest. The stake of Kim and his related parties (family and executives counted together) stayed at 11.72%.
In the company's terms
Pharmicell has 60,004,014 voting shares in issue. Counting only actual shares, the stake is 11.47%. The pledged shares equal 0.66%. The required collateral ratio is 170%.
What changes for shareholders
The pledge agreement runs until 2027.01.04.
Show Korean comments
Comments
No comments yet
Comments from shareholders will appear here.
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist